UGCG and cancer: Considering endogenous CE can subsequently be further metabolized by the enzyme glucosylceramide synthase (GCS) to yield glucosylceramide (GC) which does not have any proapoptotic activities and oppositely induce the serious multi-drug resistance (MDR), exogenous CE was introduced to preclinical study of cancer treatment [20].